Reynolds Cameron John (CIK 0001340610)

Latest company ownership

Shares held
1,041,794
Last filed at
Nov 17, 2025
Confidence Score
97.3
2025Q4
Confidence Score History
2015Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 17, 2025 Nov 17, 2025 VOLITIONRX LTD CEO Buy 67.5 +20,000 0.56% $7K
Oct 14, 2025 Oct 15, 2025 VOLITIONRX LTD CEO Buy 87.5 +110,000 3.17% $56.1K
Sep 12, 2025 Sep 15, 2025 VOLITIONRX LTD CEO Buy 60.0 +15,000 0.41% $9.9K
Aug 5, 2025 Aug 6, 2025 VOLITIONRX LTD CEO Buy 82.5 +78,125 2.19% $50K
Jun 12, 2025 Jun 16, 2025 VOLITIONRX LTD CEO Buy 60.0 +12,500 0.37% $7.4K
May 19, 2025 May 19, 2025 VOLITIONRX LTD CEO Buy 67.5 +20,000 0.60% $8.7K
Mar 26, 2025 Mar 27, 2025 VOLITIONRX LTD CEO Buy 90.0 +181,818 5.76% $100K
Dec 9, 2024 Dec 10, 2024 VOLITIONRX LTD CEO Buy 87.5 +139,811 4.63% $80K
Dec 8, 2023 Dec 11, 2023 VOLITIONRX LTD CEO Buy 60.0 +10,000 0.37% $6.7K
Aug 16, 2023 Aug 16, 2023 VOLITIONRX LTD CEO Buy 61.3 +10,000 0.40% $12.2K
Aug 30, 2022 Aug 30, 2022 VOLITIONRX LTD CEO Buy 55.0 +3,500 0.16% $5.6K
Jul 21, 2020 Jul 23, 2020 VOLITIONRX LTD CEO Sell 40.0 -83,900 -2.46% $331.4K
May 22, 2020 May 22, 2020 VOLITIONRX LTD CEO Buy 56.3 +4,000 0.18% $11K
Dec 5, 2019 Dec 6, 2019 VOLITIONRX LTD CEO Buy 55.0 +1,100 0.05% $4.7K
Aug 16, 2018 Aug 17, 2018 VOLITIONRX LTD CEO Buy 61.3 +6,500 0.30% $12.4K
Aug 16, 2017 Aug 17, 2017 VOLITIONRX LTD CEO Buy 56.3 +3,630 0.17% $10.1K
Nov 18, 2016 Nov 21, 2016 VOLITIONRX LTD CEO Sell 22.5 -13,393 -1.19% $60K
Jun 16, 2016 Jun 20, 2016 VOLITIONRX LTD CEO Sell 22.5 -23,821 -19.87% $80.8K
May 20, 2016 May 24, 2016 VOLITIONRX LTD CEO Sell 22.5 -20,340 -1.76% $72K
May 15, 2015 May 18, 2015 VOLITIONRX LTD CEO Buy 55.0 +1,500 0.14% $5K